Peter Meyer

2.6k total citations
51 papers, 1.8k citations indexed

About

Peter Meyer is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Peter Meyer has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Peter Meyer's work include Neutropenia and Cancer Infections (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (7 papers). Peter Meyer is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Acute Myeloid Leukemia Research (7 papers). Peter Meyer collaborates with scholars based in Germany, Norway and Sweden. Peter Meyer's co-authors include Melanie Barbara Boettger, Josef Flammer, Ivan O. Haefliger, Thomas F. Lüscher, Μαρία Τσολιά, Hanna Shalev, Val C. Sheffield, Gretel Beck, Roxanne Y. Walder and Zvi Borochowitz and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Peter Meyer

51 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Meyer Germany 20 516 430 355 241 226 51 1.8k
Hitoshi Takagi Japan 32 657 1.3× 649 1.5× 235 0.7× 432 1.8× 1.3k 5.7× 212 3.5k
Rachele Ciccocioppo Italy 31 417 0.8× 643 1.5× 171 0.5× 183 0.8× 1.0k 4.5× 112 3.3k
Ina Fabian Israel 29 421 0.8× 683 1.6× 111 0.3× 184 0.8× 190 0.8× 91 2.0k
Sérgio Zucoloto Brazil 28 375 0.7× 439 1.0× 112 0.3× 106 0.4× 590 2.6× 124 2.0k
Atsushi Togawa Japan 23 485 0.9× 768 1.8× 86 0.2× 157 0.7× 329 1.5× 72 2.3k
Steven N. Emancipator United States 34 141 0.3× 646 1.5× 71 0.2× 248 1.0× 187 0.8× 95 3.0k
Ayano Inui Japan 26 201 0.4× 207 0.5× 194 0.5× 84 0.3× 1.1k 4.7× 163 2.0k
Hoshio Hiraide Japan 31 598 1.2× 553 1.3× 178 0.5× 261 1.1× 491 2.2× 89 3.0k
Tjomme van der Bruggen Netherlands 19 189 0.4× 306 0.7× 117 0.3× 75 0.3× 189 0.8× 37 1.3k
Hans‐Peter Dienes Germany 31 273 0.5× 795 1.8× 191 0.5× 165 0.7× 2.2k 9.7× 57 4.0k

Countries citing papers authored by Peter Meyer

Since Specialization
Citations

This map shows the geographic impact of Peter Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Meyer more than expected).

Fields of papers citing papers by Peter Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Meyer. The network helps show where Peter Meyer may publish in the future.

Co-authorship network of co-authors of Peter Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Meyer. A scholar is included among the top collaborators of Peter Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Meyer. Peter Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reikvam, Håkon, et al.. (2021). Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis. Cancers. 13(8). 1870–1870. 17 indexed citations
2.
Hilken, Gero, et al.. (2021). The Eyes of an African Penguin (Spheniscus demersus): GeneralMorphology and Ophthalmopathology. Klinische Monatsblätter für Augenheilkunde. 239(1). 94–98. 2 indexed citations
3.
Torfoss, Dag, Lorentz Brinch, Fredrik Schjesvold, et al.. (2016). Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial. Clinical Microbiology and Infection. 23(3). 179–187. 7 indexed citations
4.
Meyer, Peter, et al.. (2012). BRCA2 Mutations and Triple-Negative Breast Cancer. PLoS ONE. 7(5). e38361–e38361. 28 indexed citations
5.
Johnsen, Svein Joar Auglænd, Johan G. Brun, Lasse G. Gøransson, et al.. (2012). Risk of Non‐Hodgkin's Lymphoma in Primary Sjögren's Syndrome: A Population‐Based Study. Arthritis Care & Research. 65(5). 816–821. 64 indexed citations
6.
Yri, Olav Erich, Dag Torfoss, Olav Hungnes, et al.. (2011). Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood. 118(26). 6769–6771. 119 indexed citations
7.
Pressler, Tacjana, Ferenc Karpati, Marta Granström, et al.. (2008). Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. Journal of Cystic Fibrosis. 8(1). 37–42. 54 indexed citations
8.
Torfoss, Dag, E. Arne Høiby, Jon Magnus Tangen, et al.. (2007). Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. Journal of Antimicrobial Chemotherapy. 59(4). 711–717. 19 indexed citations
9.
Meyer, Peter, Christine S. Zuern, Norbert Hermanns, & Thomas Haak. (2007). The association between paternal prostate cancer and type 2 diabetes. Journal of Carcinogenesis. 6(1). 14–14. 5 indexed citations
10.
Mößner, Rotraut, Peter Meyer, Inke R. König, et al.. (2006). Variations in the peroxisome proliferator-activated receptor-γ gene and melanoma risk. Cancer Letters. 246(1-2). 218–223. 12 indexed citations
11.
Carlsson, Malin, Leif Eriksson, T. Pressler, et al.. (2006). Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. Journal of Cystic Fibrosis. 6(3). 228–233. 36 indexed citations
12.
Boettger, Melanie Barbara, Consolato Sergi, & Peter Meyer. (2003). BRCA1/2 mutation screening and LOH analysis of lung adenocarcinoma tissue in a multiple-cancer patient with a strong family history of breast cancer.. Journal of Carcinogenesis. 2(1). 5–5. 10 indexed citations
13.
Meyer, Peter, Consolato Sergi, & Claus Garbe. (2003). Polymorphisms of the BRAF gene predispose males to malignant melanoma.. Journal of Carcinogenesis. 2(1). 7–7. 32 indexed citations
14.
Meyer, Peter & F Gudat. (1998). Das Non-Hodgkin-Lymphom der Conjunctiva (MALT-Lymphom) - Klinische und pathologische Merkmale. Klinische Monatsblätter für Augenheilkunde. 212(5). 407–409. 1 indexed citations
15.
Lang, Markus, Peili Zhu, Peter Meyer, et al.. (1997). Amlodipine and benazeprilat differently affect the responses to endothelin-1 and bradykinin in porcine ciliary arteries: effects of a low and high dose combination. Current Eye Research. 16(3). 208–213. 13 indexed citations
16.
Boege, Fritz, Harald Biersack, & Peter Meyer. (1994). Drug-Sensitivity and DNA-Binding of a Subform of Topoisomerase Iiα in Resistant Human HL-60 Cells. Acta Oncologica. 33(7). 799–806. 4 indexed citations
17.
18.
Ho, Anthony D., T. Lipp, Gerhard Ehninger, et al.. (1988). Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.. Journal of Clinical Oncology. 6(2). 213–217. 116 indexed citations
19.
Meyer, Peter, et al.. (1988). Comparative Study of Ceftriaxone and Cefoperazone in the Treatment of Acute Cholecystitis. Chemotherapy. 34(1). 30–33. 4 indexed citations
20.
Ehninger, Gerhard, et al.. (1985). Mitoxantrone in the Treatment of Relapsed and Refractory Acute Leukemia. Oncology Research and Treatment. 8(3). 146–148. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitoshi Takagi Breakdown of academic impact, for papers by Rachele Ciccocioppo Breakdown of academic impact, for papers by Ina Fabian Breakdown of academic impact, for papers by Sérgio Zucoloto Breakdown of academic impact, for papers by Atsushi Togawa Breakdown of academic impact, for papers by Steven N. Emancipator Breakdown of academic impact, for papers by Ayano Inui Breakdown of academic impact, for papers by Hoshio Hiraide Breakdown of academic impact, for papers by Tjomme van der Bruggen Breakdown of academic impact, for papers by Hans‐Peter Dienes
Rankless by CCL
2026